AUCTORES
Globalize your Research
Chat with us
Review Article | DOI: https://doi.org/10.31579/2640-1053/200
*Corresponding Author: Ahmad Reza Rahnemoon. Retired at hematology department, I.U.M.S, Tehran, Iran.
Citation: Ahmad R. Rahnemoon, (2024), Niche remodeling during aging process. J. Cancer Research and Cellular Therapeutics. 8(4); DOI:10.31579/2640-1053/200
Copyright: © 2024, Ahmad Reza Rahnemoon. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 01 July 2024 | Accepted: 10 July 2024 | Published: 18 July 2024
Keywords: Niche; aging; remodeling; hematopoietic malignancy
Aging of hematopoietic system might result from hematopoietic stem cell (HSC) and micro-environmental alterations with changes at the location, regulation and function of HSC and their progeny. Hereby, we can state the relative contribution of the aged micro-environment and the graduate alterations which changed hematopoiesis and increased incidence of age-related diseases originating in the bone marrow environment. Here, we focus on a better understanding of the biology of aging in HSCs and their niche. In summary, studies on the micro-environment that maintains and regulates HSC and its niche suggested that micro-environmental aging contributes to declined HSC function over time. After this period, aged HSCs and their derivatives remodel the niche in changing to favor myeloid expansion.
Niche specific cell populations, varied growth factors, extra cellular matrix and cell adhesion molecules produced by niche cells are integrated with each other for controlling stem cell behavior common goal. It is mentionable that HSCs locate in unique niches which offers a pivotal microenvironment for HSC quiescence, activation, differentiation and expansion. In this pathway, mature blood and immune cells are generated by hematopoiesis which has been modeled as a stepwise differentiation process in the core of which reside HSCs. Thus, early hematopoiesis is now viewed as a continuous landscape composed of undifferentiated HSCs with a variable degree of priming toward specific lineages including lymphoid, myeloid or erythroid base on a tree-like hierarchy arises from HSCs in which lineage commitment occurs at binary branching points to homogenous progenitor populations. In the better words, the BM niche is comprised of many different cell types including mesenchymal stromal cells, osteo-progenitor derivatives, endothelial cells, adipocytes, sympathetic nervous system and blood of specific immature and mature cells such as megakaryocytes as well as monocyte, neutrophil and erythroid precursors. [12,13,21,22]
Figure 1: Schematic model in autophagy inhibition, MSCs dysfunction and bone loss. (27)
Arch and chip:
Clonal populations existence in the BM, identified the expansion of more than one genetically distinct cell populations, is increasingly being viewed as a phenomenon in age related inflammation or the age associated surge in systemic inflammation. Recent characterization of clonal hematopoiesis in a large segment of aging population has raised tremendous interest and concern alike. Mutations have been documented in genes associated with hematological cancers. So in challenging between clonality and malignancy, age related clonal hematopoiesis (ARCH) refer to clonal hematopoiesis caused by any type of acquired clonal event or ARCH describe as an inevitable consequence of aging which in this condition, many of the intrinsic aspects of HSC are affected by the aging process resulting in a deterioration in their potential, independently of their microenvironment. But clonal hematopoiesis of indeterminate potential (CHIP) refers to the mutation of a gene like DNMT3A, TET2, etc. with a variant allele frequency greater than 2% that happen in 10%-40 % cases and can progress to an increased risk of blood cancers as well. Hence, these potent clones with: a) increasing age, b) genomic instability, c) age related inflammation and at last external environmental cues that can accumulate in the BM, reaching a stage known as CHIP. Notably, when the hematopoiesis become abnormal or marked by additional mutations acquisition as well as other additional external factors, the malignancy can appear. [1-4,7-10]
In reality, on the one hand, some mutations can establish as a detectable clone of hematopoietic cells in healthy individuals which lacking any hematological cancer evidence. Hence, the clonal hematopoiesis becomes commoner with age and can detect in the people aged particularly in 90 years or even older, which can appear acquire additional mutations such as FLT3 or NPM1 that go to generate into the expansion of acute leukemia. Also, the number and frequency of HSC in the BM of mice and humans increase with aging, while their regenerative capacity measured in transplantation assays in clearly reduced, notably that is caused primarily by cell intrinsic mechanism even though an aged microenvironment can further aggravate it. So that’s why, hematopoietic function severely decline with age, also sometimes anemia, impaired adaptive immunity, autoimmune disease and cancer may be happened in the elderly. Aging can lead to major changes in bone and BM cavity which provide specialized niches for introduce the distinguished role of HSC in the niche. Now, this is clear that intrinsic changes in the BM microenvironment contribute to old HSC dysfunction but the concept and mechanisms driving niche aging much less is known and additionally the role of influence of old niche on hematopoietic aging. In the other words, during aging, the hematopoietic system can be with various changes including increase in the relative number of HSCs that presumably aims to compensate for a repopulation ability loss (figure 1). So, increasing in HSCs and decreasing in total BM cellularity may be happened, also lymphocyte production loss, increase in the number of platelet primed HSCs and a skewing toward myeloid differentiation have been demonstrated. Generally, loss of immune function that affects innate and adaptive immunity together has been reported. So, as mentioned above, ARCH is defined as the expansion of HSC clones, harboring specific, recurrent genetic variants and disruptive without any hematologic malignancy because, ARCH in human blood system occur in B and T cells, also in cells of the innate system and HSCs as well. [5,6,11-17]
Figure 2: ARCH is defined as the gradual, clonal expansion of HSC 0r other progenitor cells carrying specific, disruptive to changes in the micro-environmental niche and recurrent genetic variants which can increase the risk for pre-leukemia or/and leukemia as well. [1]
It is mentionable that some ARCH cases are clearly pre-leukemic (will certainly evolve to leukemia) as was demonstrated by several researchers. Actually, pre-leukemia referred to a heterogeneous group of hematopoietic disorders associated with a block in myeloid differentiation as well as chronic cytopenias. In pre-leukemia position appear to have an identical clonality of both myeloid and lymphoid compartments. It suggest that the
clone can initiate in a very early hematopoietic stem cell. In this case, the mutant genes involve in ineffective dysplastic hematopoiesis pathway. In other words, some driver mutations produce an essential block in differentiation providing a proliferative advantage to the clone cells. In fact, chronic inflammation or exposure to specific environmental stimulus might allow such clones to become dominant.
Figure 3: ARCH is the clonal expansion of at least single HSCs capable of multi-lineage differentiation. Please look at genetic alterations after clonal expansion of cancer cell and additionally the important role of disruptive influences of cancer cells in the hematopoietic micro-environment. (Google website)
For example, among elderly who received chemotherapy and developed therapy induced MDS/AML, 62% had ARCH before chemotherapy, however 15% of match controls (who did not develop MDS/AML) had ARCH. Taken together these studies indicate that there is a clear relationship between ARCH and CHIP, but more CHIP specifically to the malignant hematopoietic development (figure 2). Although, some researchers stated that when clonal hematopoiesis documented in individuals with unexplained cytopenia and no CHIP criteria, the positive predictive value of progression to a myeloid cancer is very high. It is important to consider that ARCH related mutations may have distinct functional consequences during ARCH evolution and later during leukemia progression to leukemia clones evolution (figures 2, 3 & 4). That’s why, clonal hematopoiesis offers a new opportunity to understand the important role of niche and also the biology and adaption mechanisms of aging and malignant transformation mechanism as well. Therefore, cancer is not a single disease but instead is morphological and biological features. As a result, cancer stem cells (CSCs)reside at the apex of the hierarchy and are thought to possess the cancer initiating cells, their microenvironment and metastatic ability as well. [1-9]
Hematopoietic aging:
Hematopoietic aging is marked by a loss of regenerative capacity and skewed differentiation from HSCs leading to impaired blood production which is tailored in part by differential production of distinct HSC derived multi-potent progenitor subsets with specific myeloid or lymphoid lineage biases that in turn give rise to an array of lineage restricted progenitors, precursors and mature cells. So, the BM niche is comprised of many different cell types which described important age-related changes in individual niche components, specially in the vasculature (like fragilization of the vasculature), innervation, specific stromal populations as well as reported heightened inflammation in the aged marrow cavity particularly inflammatory remodeling of central marrow populations. In addition, HSC can bypass the intermediate steps to generate mature progenies under the conditions like aging and chronic inflammation. These changes create a self-reinforcing cycle of damage that drives lineage biases and regenerative response defects from the aged blood system which localized inflammation drives the constitutive activation of emergency myelopoiesis pathways particularly from old HSCs and MPPs, reinforcing myeloid cell production in the erythroid and lymphoid commitment expense. But the question, may niche alterations predispose to hematologic neoplasm in the situation? In response, during aging, remodeling of the BM endothelial vasculature is notable. So, on age related BM niche remodeling, the key micro-environmental players and their associated mechanisms with the HSC localization are very important. Supposedly, in MDS, abnormal cytokines production from the microenvironment, MSC and osteolineage cells dysfunction as well as vascular remodeling have been associated with the initiation and progression of disease. (figures 3 & 4) [1-3,14-20].
Figure 4: A model of the interplay between HSCs and the micro-environment during aging. The alterations in specialized niches might affect lymphoid/myeloid output directly and to accumulation of aged HSCs in the central BM and in the imbalanced mature HSCs production at particular niches might in turn remodel the micro-environment for these cells which can increase aged-related hematopoietic disorders incidence. [3]
In the end, aging is a heterogeneous process leading to impairment, malfunction as well as failure of cells and tissues. One of the hallmarks of aging relates to stem cell exhaustion which means aged HSCs have a diminished functional capacity while the increase number of HSCs seems to be a compensatory mechanism in order to maintain blood production. Another characteristic of aged HSCs is their distorted and skewed differentiation potential as well. Told all, in aging, after HSCs increased in number and impaired in functions which characterized by reduced regenerative and homing capacity, loss of cell polarity and myeloid biased differentiation at the expense of lymphopoiesis may be happened. These changes were thought initially to cause only cell-intrinsic deregulation like epigenetic deregulation, deficient DNA repair and replication stress. Also, old HSC suffer metabolic changes, impaired autophagy and altered protein hemostasis that contribute to their regenerative potential decline. [1-4,20-25,27]
Hematologic malignancies:
Many hematologic disorders including anemia and hematologic malignancies are more common with aging. So, compared with younger adults, older adults are more likely to have age related vulnerabilities such as functional and cognitive impairment. Therefore, the hematopoietic system is affected by this process in different ways such as clonal hematopoiesis (CH) with unexplained cytopenias which the progression to a myeloid cancer should be increased. But why? Because firstly, these patients with clonal cytopenia have a higher risk of developing a myeloid neoplasm significantly than those with no evidence of clonality. Secondly, morphologic evidence of dysplasia and MDS-specific cytogenetic abnormalities together which can be important in the malignant hematopoietic process. In summary, unexplained cytopenia is a rare hematologic disorder, while caution should be taken in unexplained cytopenia cases because the possible transformation of the disease to MDS or AML. Regarding this point, some researchers revealed a decreased survival in cases with CH as compared to cases without CH in unexplained cytopenia. In other report, specific ARCH mutations were identified among 64% of individuals with unexplained cytopenia and no history of any blood neoplasms but eventually many of these individuals suffered from myeloid malignancies as well.
Figure 5: Hypothetical model of evolution from age related clonal hematopoiesis to MBL (monoclonal B-cell lymphocytosis and CLL (chronic lymphocytic leukemia), although we know ARCH can find in some hematological malignancies like AML, CLL, MDS or others. But CLL is happened after third hit, not earlier than It. Why? [26]
It is noticeable that in some malignant hematopoietic diseases with normal genetic state, the concept of BM abnormality can be acceptable as the central and essential role, particularly on seizing in controlling of hematopoietic microenvironment pathway and their cellular functions and in the deregulation of hematopoietic pathway. [1-3, 15-17, 28-29]
Clonal hematopoiesis is a common trait of elderly persons in which blood cell populations are clonally derived from a single HSC or progenitor with acquired mutation. In fact, ARCH is a heterogeneous entity with a common feature including the expansion of specific HSCs and their progenitors. Several ARCH-related mutations can increase hematopoietic malignancy. Therefore, the clonal evolution suggests that the successive mutations accumulating in a given cell generate clonal outgrowths that thrive in response to micro-environmental selection pressures, dictating the phenotype of the malignancy which means the malignancy like myeloid malignancy defining the notion of CHIP. Anyhow, aging of the hematopoietic system might result from both HSC-intrinsic and micro-environmental alterations with changes in regulation, function and location of HSCs and their progeny, so this is a reason why the interconnections between these biological processes will be a key aspect in deciphering the extent of the impact of aging on HSC. Interestingly, the niche alterations are shared between aging and myeloid disorders associated with age which an important selection pressure to expand aberrant HSC clones which can go to hematopoietic malignancy. Thus, as a result, these actions can expand our understanding on the architecture of abnormal BM niche and its construction in aging particularly in changing to leukemic diseases (figures 4&5).
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
